Diagnosing Invasive Candidiasis
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Cultures are negative in ∼50% of invasive candidiasis. Data are emerging for the performance of nonculture tests such as mannan/antimannan, Candida albicans germ tube antibody, 1,3-β- d -glucan, PCR, and the T2Candida panel in diagnosing both candidemia and deep-seated candidiasis. In most settings, positive predictive values of nonculture test are low, and negative predictive values are high. For tests to be useful, clinicians must understand the pretest likelihood of invasive candidiasis and test performance for the most common disease manifestation in a given patient. This paper reviews nonculture Candida diagnostics and discusses how they might be used effectively in patient care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“One limitation is that we may be missing sterile site infections as well as candidemic patients with deep-seated infections due to limitations with current detection methods [28].”
From Invasive candidiasis species distribution and trends, United States, 2009-2017 (2021) · cites this paper as [28]
The cited source says what the claim attributes to it.
In the citing paper
“with the sensitivity of blood culture around or less than 50% [28].”
From Invasive candidiasis species distribution and trends, United States, 2009-2017 (2021) · cites this paper as [28]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Other studies, however, did not observe an association between antimicrobial timing and mortality (112-117).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [115]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Andes, D. R., Safdar, N., Baddley, J. W., Playford, G., Reboli, A. C., Rex, J. H., Sobel, J. D., Pappas, P. G., Kullberg, B. J., & for the Mycoses Study Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis021 · Cited by 793 · cited 1×
“Timely antifungal therapy and source control are crucial determinants of survival in patients with invasive candidiasis (1, 2).”
BackgroundClancy, C. J., & Nguyen, M. H. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit006 · Cited by 688 · cited 5×
“Cultures of material collected from deep sites of infection are also only 50% sensitive, likely reflecting small sample volumes and uneven distribution and low burdens of Candida cells (3).”
BackgroundInfluentialSelf-citation-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis
Karageorgopoulos, D. E., Vouloumanou, E. K., Ntziora, F., Michalopoulos, A., Rafailidis, P. I., & Falagas, M. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq206 · Cited by 538 · cited 1×
“65% to 85% and 75% to 85%, respectively) (12, 13).”
T2 Magnetic Resonance Assay for the Rapid Diagnosis of Candidemia in Whole Blood: A Clinical Trial
Mylonakis, E., Clancy, C. J., Ostrosky-Zeichner, L., Garey, K. W., Alangaden, G. J., Vazquez, J. A., Groeger, J. S., Judson, M. A., Vinagre, Y.-M., Heard, S. O., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu959 · Cited by 443 · cited 10×
“FDA clearance of T2Candida was based on data from the multicenter DIRECT trial, which included 1,500 control patients with Candida-negative blood cultures, 6 patients with Candida-positive blood cultures, and 250 contrived blood specimens spiked with C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, or C. krus…”
InfluentialSelf-citationPCR Diagnosis of Invasive Candidiasis: Systematic Review and Meta-Analysis
Avni, T., Leibovici, L., & Paul, M. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01602-10 · Cited by 389 · cited 1×
“and 92% (95% CI, 87 to 98%), respectively (17).”
Onishi, A., Sugiyama, D., Kogata, Y., Saegusa, J., Sugimoto, T., Kawano, S., Morinobu, A., Nishimura, K., & Kumagai, S. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.05267-11 · Cited by 328 · cited 1×
“65% to 85% and 75% to 85%, respectively) (12, 13).”
Mikulska, M., Calandra, T., Sanguinetti, M., Poulain, D., Viscoli, C., & the Third European Conference on Infections in Leukemia Group (2010) · Critical Care · doi:10.1186/cc9365 · Cited by 319 · cited 1×
“In a meta-analysis of 14 studies, the sensitivities and specificities of mannan and antimannan for invasive candidiasis were 58% and 93%, and 59% and 86%, respectively (7).”
BackgroundNguyen, M. H., Wissel, M. C., Shields, R. K., Salomoni, M. A., Hao, B., Press, E. G., Shields, R. M., Cheng, S., Mitsani, D., Vadnerkar, A., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis200 · Cited by 290 · cited 2×
“The sensitivity and specificity of PCR are estimated from the studies of deep-seated candidiasis cited in the text and in Table 1 (9, 10, 22).”
BackgroundSelf-citationPfaller, M. A., Messer, S. A., Moet, G. J., Jones, R. N., & Castanheira, M. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.02.016 · Cited by 274 · cited 6×
“FDA clearance of T2Candida was based on data from the multicenter DIRECT trial, which included 1,500 control patients with Candida-negative blood cultures, 6 patients with Candida-positive blood cultures, and 250 contrived blood specimens spiked with C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, or C. krus…”
BackgroundInfluentialLaboratory diagnosis of invasive candidiasis.
Ellepola, A. N. B., & Morrison, C. J. (2005) · PubMed · Cited by 265
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Donnelly, J. P., Chen, S. C., Kauffman, C. A., Steinbach, W. J., Baddley, J. W., Verweij, P. E., Clancy, C. J., Wingard, J. R., Lockhart, S. R., Groll, A. H., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1008 · Cited by 2,917
“This includes patients with hematologic malignancies with and without neutropenia, neutropenia following HSCT, and certain patients in the ICU who are at higher risk (>10%) for IC as a result of gastrointestinal surgery with recurrent anastomotic leaks, perforations of the upper gastrointestinal tract, or necrotizing…”
BackgroundSelf-citationSong, G., Liang, G., & Liu, W. (2020) · Mycopathologia · doi:10.1007/s11046-020-00462-9 · Cited by 644
Estimation of Direct Healthcare Costs of Fungal Diseases in the United States
Benedict, K., Jackson, B. R., Chiller, T., & Beer, K. D. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy776 · Cited by 438
“Early detection is especially important in patients at high risk for developing invasive fungal diseases; examples of existing strategies include galactomannan assay for aspergillosis and β-D-glucan and T2Candida for invasive candidiasis [34].”
BackgroundLass-Flörl, C., Kanj, S. S., Govender, N. P., Thompson, G. R., Ostrosky- Zeichner, L., & Govrins, M. A. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00503-3 · Cited by 298
“Candidaemia is a low-prevalence disease and varies from 1% to 10% 117 .”
Arastehfar, A., Carvalho, A., Nguyen, M. H., Hedayati, M. T., Netea, M. G., Perlin, D. S., & Hoenigl, M. (2020) · Journal of Fungi · doi:10.3390/jof6040211 · Cited by 272
“Combining multiple techniques is recommended in order to improve the sensitivity of the techniques [64,77,78].”
BackgroundMethodSelf-citationCandidemia and Invasive Candidiasis
McCarty, T. P., White, C. M., & Pappas, P. G. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.007 · Cited by 260
“108 The diagnosis of IAC is typically based on the isolation of Candida species from sterilely obtained specimens and/or positive non–culture-based diagnostics (eg, b -”
Invasive candidiasis: current clinical challenges and unmet needs in adult populations
Soriano, A., Honore, P. M., Puerta-Alcalde, P., Garcia-Vidal, C., Pagotto, A., Gonçalves-Bradley, D. C., & Verweij, P. E. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad139 · Cited by 190
COVID-19-associated opportunistic infections: a snapshot on the current reports
Abdoli, A., Falahi, S., & Kenarkoohi, A. (2021) · Clinical and Experimental Medicine · doi:10.1007/s10238-021-00751-7 · Cited by 184
Initial antimicrobial management of sepsis
Niederman, M. S., Baron, R. M., Bouadma, L., Calandra, T., Daneman, N., DeWaele, J., Kollef, M. H., Lipman, J., & Nair, G. B. (2021) · Critical Care · doi:10.1186/s13054-021-03736-w · Cited by 180
“negative in 30% to 50% of candidemia patients and in 80% to 90% of patients with primary deep-seated candidiasis [105].”
BackgroundDiagnosis and Treatment of Invasive Candidiasis
Barantsevich, N., & Barantsevich, E. (2022) · Antibiotics · doi:10.3390/antibiotics11060718 · Cited by 178
“The first non-cultural diagnostic tools for invasive candidiasis were tests based on Candida antigens and anti-Candida antibody detection in patients’ serum [67].”
BackgroundMethodInfluentialBloodstream infections: mechanisms of pathogenesis and opportunities for intervention
Holmes, C. L., Albin, O. R., Mobley, H. L. T., & Bachman, M. A. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01105-2 · Cited by 183
“In addition, the pathogen may only circulate sporadically, and cultures may be negative, as exemplified by the diagnosis of Candida species 200 .”
A New Age in Molecular Diagnostics for Invasive Fungal Disease: Are We Ready?
Kidd, S. E., Chen, S. C.-A., Meyer, W., & Halliday, C. L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02903 · Cited by 166
Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management
Thompson, G. R., Jenks, J. D., Baddley, J. W., Lewis, J. S., Egger, M., Schwartz, I. S., Boyer, J., Patterson, T. F., Chen, S. C. ‐., Pappas, P. G., et al. (2023) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-23 · Cited by 167
“However, quantitative PCR (qPCR) testing for Candida is not yet commercially available and, despite its potential utility for monitoring patients for recurrence or determining responses to therapy, its role in the diagnosis of Candida endocarditis is currently unclear (13, 119).”
BackgroundAslam, S., Rotstein, C., & Practice, T. A. I. D. C. O. (2019) · Clinical Transplantation · doi:10.1111/ctr.13623 · Cited by 160
Diagnosis and treatment of invasive fungal infections: looking ahead
Sanguinetti, M., Posteraro, B., Beigelman‐Aubry, C., Lamoth, F., Dunet, V., Slavin, M. A., & Richardson, M. D. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz041 · Cited by 130
Candida glabrata: A Lot More Than Meets the Eye
Kumar, K., Askari, F., Sahu, M. S., & Kaur, R. (2019) · Microorganisms · doi:10.3390/microorganisms7020039 · Cited by 128
“krusei, is increasingly being used for rapid Candida species detection in hospital settings [15,16].”
BackgroundInvasive candidiasis species distribution and trends, United States, 2009-2017
Ricotta, E. E., Lai, Y. L., Babiker, A., Strich, J. R., Kadri, S. S., Lionakis, M. S., Prevots, D. R., & Adjemian, J. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa502 · Cited by 114
“1300 • jid 2021:223 (1 April) • Ricotta et al than 50% [28].”
BackgroundStrategies to Prevent Transmission of Candida auris in Healthcare Settings
Ahmad, S., & Asadzadeh, M. (2023) · Current Fungal Infection Reports · doi:10.1007/s12281-023-00451-7 · Cited by 77
Clinical Manifestations of Human Exposure to Fungi
Oliveira, M. T. D. S., de Oliveira, D. M., Lisboa, C., Boechat, J. L., & Delgado, L. (2023) · Journal of Fungi · doi:10.3390/jof9030381 · Cited by 96
“Deep-seated candidiasis results from the non-hematogenous introduction of Candida species into sterile sites, mainly the abdominal cavity, following gastrointestinal tract disruption or via an infected peritoneal catheter [208].”
BackgroundHaydour, Q., Hage, C. A., Carmona, E. M., Epelbaum, O., Evans, S. E., Gabe, L. M., Knox, K. S., Kolls, J. K., Wengenack, N. L., Prokop, L. J., et al. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201811-766oc · Cited by 94
Segrelles‐Calvo, G., Araújo, G. R. D. S., Pastor, E. L., Carrillo, J., Hernández‐Hernández, M., Rey, L., Melean, N. R., Escribano, I., Antón, E. G., Zamarro, C., et al. (2021) · Respiratory Medicine · doi:10.1016/j.rmed.2021.106619 · Cited by 82
“To make matters worse, these patients may also receive immunosuppressive (IS) medication, such as systemic corticosteroids (SC), tocilizumab (TCZ) and cyclosporine (CP) that are, on one hand, fundamental to halt the “cytokine storm” that occurs in the most severe cases [8,9]”
Viana, R. L. S., Fidelis, G. P., de Medeiros, M. J. C., Morgano, M. A., Alves, M. G. D. C. F., Passero, L. F. D., Pontes, D. L., Theodoro, R. C., Arantes, T. D., Sabry, D. A., et al. (2020) · Biomolecules · doi:10.3390/biom10091235 · Cited by 63
“These two genera cause candidiasis [3] and cryptococcosis [4], respectively.”
BackgroundInvasive fungal infections in acute and chronic liver impairment: A systematic review
Lahmer, T., Pietrobom, P. M. P., Schmid, R. M., & Colombo, A. L. (2021) · Mycoses · doi:10.1111/myc.13403 · Cited by 61
Inkjet printing of paraffin on paper allows low-cost point-of-care diagnostics for pathogenic fungi
Prabhu, A., Nandagopal, M. S. G., Yegneswaran, P. P., Singhal, H. R., & Mani, N. K. (2020) · Cellulose · doi:10.1007/s10570-020-03314-3 · Cited by 60
Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?
Soulountsi, V., Schizodimos, T., & Kotoulas, S. (2021) · Infection · doi:10.1007/s15010-021-01640-7 · Cited by 59
Parslow, B. Y., & Thornton, C. R. (2022) · Microorganisms · doi:10.3390/microorganisms10061208 · Cited by 59
“This is due to the current difficulties in diagnosing deep-seated infection, meaning these disease events are largely under-ascertained [9,10].”
BackgroundInfluentialThe Evolving Landscape of Fungal Diagnostics, Current and Emerging Microbiological Approaches
Weiss, Z., Leon, A., & Koo, S. (2021) · Journal of Fungi · doi:10.3390/jof7020127 · Cited by 57
Diagnosis of Invasive Candidiasis: From Gold Standard Methods to Promising Leading-edge Technologies
Pitarch, A., Nombela, C., & Gil, C. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666181025093146 · Cited by 56
“9 On the contrary, these are useless for the detection of deep-seated candidiasis in the absence of candidemia [16, 53].”
BackgroundInfluentialAsadzadeh, M., Mokaddas, E., Ahmad, S., Abdullah, A. A., de Groot, T., Meis, J. F., & Shetty, S. A. (2022) · Mycoses · doi:10.1111/myc.13419 · Cited by 55
Oliva, A., Rosa, F. G. D., Mikulska, M., Pea, F., Sanguinetti, M., Tascini, C., & Venditti, M. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2240956 · Cited by 51
“Furthermore, blood cultures may require a significant amount of time to yield positive results, potentially leading to delays in initiating appropriate antifungal treatment [77,78].”
BackgroundHsu, A. J., Tamma, P. D., & Zhang, S. X. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.03276-20 · Cited by 50
“, ICU patients at risk for candidemia) (95), a negative serum beta-D-glucan result can be helpful for stewardship efforts to”
BackgroundPublic Health Research Priorities for Fungal Diseases: A Multidisciplinary Approach to Save Lives
Smith, D. J., Gold, J. A. W., Benedict, K., Wu, K., Lyman, M., Jordan, A., Medina, N., Lockhart, S. R., Sexton, D. J., Chow, N. A., et al. (2023) · Journal of Fungi · doi:10.3390/jof9080820 · Cited by 49
Biofilm-Associated Candidiasis: Pathogenesis, Prevalence, Challenges and Therapeutic Options
Amann, V., Kissmann, A., Firacative, C., & Rosenau, F. (2025) · Pharmaceuticals · doi:10.3390/ph18040460 · Cited by 48
“Faster, non-culture methods for identifying Candida infections include mannan and anti-mannan antibody detection [30,242,245], β -D-glucan (BDG) detection [230], C. albicans germ tube antibody (CAGTA) detection [246], PCR detection of Candida DNA [247] and the T2 magnetic resonance (T2MR) Candida…”
An overview of using fungal DNA for the diagnosis of invasive mycoses
White, P. L., Alanio, A., Brown, L., Cruciani, M., Hagen, F., Gorton, R., Lackner, M., Millon, L., Morton, C. O., Rautemaa‐Richardson, R., et al. (2022) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2022.2037423 · Cited by 50
S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge – Update 2025
Brunkhorst, F. M., Adamzik, M., Axer, H., Bauer, M. W., Bode, C., Bone, H.-G., Brenner, T., Bucher, M., David, S., Dietrich, M., et al. (2025) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-025-01317-1 · Cited by 47
Fungal Infections in Liver Transplant Recipients
Scolarici, M. J., Jorgenson, M. R., Saddler, C. M., & Smith, J. A. (2021) · Journal of Fungi · doi:10.3390/jof7070524 · Cited by 46
“In a study involving nonliver-transplant recipients, the sensitivity of blood cultures for the detection of IC was only ~50% [17], and cultures are often negative despite deep-seated infections, such as intra-abdominal infections common after liver transplantation.”
BackgroundCOVID-19 and Fungal infections: a double debacle
Mina, S., Yaakoub, H., Annweiler, C., Dubée, V., & Papon, N. (2022) · Microbes and Infection · doi:10.1016/j.micinf.2022.105039 · Cited by 46
“However, the sensitivity of blood cultures is approximately 50% when diagnosing invasive candidiasis due to the low numbers of fungal cells [98].”
Challenges and research priorities to progress the impact of antimicrobial stewardship
Bassetti, M., Giacobbe, D. R., Vena, A., & Brink, A. J. (2019) · Drugs in Context · doi:10.7573/dic.212600 · Cited by 45
Diagnostic Performance of a Novel Multiplex PCR Assay for Candidemia among ICU Patients
Fuchs, S., Lass‐Flörl, C., & Posch, W. (2019) · Journal of Fungi · doi:10.3390/jof5030086 · Cited by 45
“In comparison, Candida nucleic acid detection by real-time PCR assays is mainly done using in-house protocols with varying sensitivities and specificities [18,19].”
MethodКirov, М. Y., Владимирович, К. В., Николаевич, П. Д., Щеголев, А. В., Babaev, M. A., Belotserkovskiy, B. Z., Bykov, A. O., Gritsan, A. I., Кулабухов, В. В., Kulikov, A. V., et al. (2023) · Annals of critical care · doi:10.21320/1818-474x-2023-4-7-42 · Cited by 44
Poole, S., Kidd, S. P., & Saeed, K. B. A. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1480369 · Cited by 44
Biomarkers of fungal infection: Expert opinion on the current situations
Instituto de Investigación Sanitaria Gregorio Marañón Servicio de Microbiología Clínica y E. Infecciosas C/ Dr. Esquerdo, 4. 2. M., Bouza, E., Almirante, B., García Rodríguez, J., Garnacho-Montero, J., Salavert, M., Muñoz, P., Patricia Muñoz, M., & Sanguinetti, M. (2020) · Revista Española de Quimioterapia · doi:10.37201/req/2260.2019 · Cited by 39
Satała, D., Gonzalez‐Gonzalez, M., Smolarz, M., Surowiec, M., Kulig, K., Wronowska, E., Zawrotniak, M., Kozik, A., Rąpała‐Kozik, M., & Karkowska‐Kuleta, J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.765942 · Cited by 45
“Nevertheless, its main disadvantages are the possibility of detection of only viable and culturable Candida cells, prolonged waiting time for results, and low sensitivity, as almost half of the cases of invasive candidiasis remain undiagnosed (Clancy and Nguyen, 2013; Clancy and Nguyen, 2018).”
BackgroundPerformance of the T2Candida Panel for the Diagnosis of Intra-abdominal Candidiasis
Lamoth, F., Clancy, C. J., Tissot, F., Squires, K., Eggimann, P., Flückiger, U., Siegemund, M., Orasch, C., Zimmerli, S., Calandra, T., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa075 · Cited by 39
“However, serum BDG assays are limited by lack of specificity and high false positivity [4, 5].”
BackgroundSelf-citationThe rise in cases of mucormycosis, candidiasis and aspergillosis amidst COVID19
Ghosh, A., Sarkar, A., Paul, P., & Patel, P. K. (2021) · Fungal Biology Reviews · doi:10.1016/j.fbr.2021.09.003 · Cited by 41
Al-Obaid, I., Asadzadeh, M., Ahmad, S., Alobaid, K., Alfouzan, W., Bafna, R., Emara, M., & Joseph, L. (2022) · Journal of Fungi · doi:10.3390/jof8030267 · Cited by 39
Candida kefyr in Kuwait: Prevalence, antifungal drug susceptibility and genotypic heterogeneity
Ahmad, S., Khan, Z., Al‐Sweih, N., Alfouzan, W. A., Joseph, L., & Asadzadeh, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240426 · Cited by 37
Advances in the diagnosis of fungal pneumonias
Kelly, B. T., Pennington, K. M., & LIMPER, A. H. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1753506 · Cited by 36
“T2Candida panel is an FDA approved test that detects Candida directly within the whole blood and can be used for candidemia (Table 2) [31].”
BackgroundMethodInfluentialUses of Procalcitonin as a Biomarker in Critical Care Medicine
Maves, R. C., & Enwezor, C. H. (2022) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2022.07.004 · Cited by 37
Diagnosing fungal infections in clinical practice: a narrative review
Sedik, S., Wolfgruber, S., Hoenigl, M., & Kriegl, L. (2024) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2024.2403017 · Cited by 34
“Candida spp. cultures are highly efficient, typically giving positive results at a median concentration of 1 CFU/ml, indicating their ability to detect viable Candida cells [77].”
Use of (1→3)‐β‐ d ‐glucan for diagnosis and management of invasive mycoses in HIV ‐infected patients
Farhour, Z., Mehraj, V., Chen, J., Ramendra, R., Lu, H., & Routy, J. (2018) · Mycoses · doi:10.1111/myc.12797 · Cited by 33
“This triggers a coagulation cascade which can be used to subsequently quantify BDG concentrations using colorimetric methods similar to that of an enzyme linked immunosorbent assay (ELISA).(17)”
MethodTropical Medicinal Plant Extracts from Indonesia as Antifungal Agents against Candida Albicans
Geraldi, A., Wardana, A. P., Aminah, N. S., Kristanti, A. N., Sadila, A. Y., Wijaya, N. H., Wijaya, M. R. A., Diningrum, N. I. D., Hajar, V. R., & Manuhara, Y. S. W. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2709274 · Cited by 33
de Almeida, B. G., Lemes, T. H., Byzynski, G., Paziani, M. H., Kress, M. R. V. Z., de Almeida, M. T. G., & Volanti, D. P. (2019) · ACS Applied Nano Materials · doi:10.1021/acsanm.9b00091 · Cited by 33
Wang, K., Luo, Y., Zhang, W., Xie, S., Yan, P., Liu, Y., Li, Y., Ma, X., Xiao, K., Fu, H., et al. (2019) · Mycoses · doi:10.1111/myc.13035 · Cited by 33
Invasive Candidiasis in the Intensive Care Unit: Where Are We Now?
Vázquez, J. A., Whitaker, L., & Zubovskaia, A. (2025) · Journal of Fungi · doi:10.3390/jof11040258 · Cited by 32
“For the diagnosis of IC, findings from laboratory studies are non-specific and lack sensitivity [32,33].”
InfluentialThe SSS revolution in fungal diagnostics: speed, simplicity and sensitivity
Baker, J., & Denning, D. W. (2023) · British Medical Bulletin · doi:10.1093/bmb/ldad011 · Cited by 32
Schroeder, J. A., Wilson, C. M., & Pappas, P. G. (2024) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2024.11.007 · Cited by 32
Schelenz, S., Abdolrasouli, A., Armstrong-James, D. P. H., Ashbee, H. R., Barton, R., Bicanic, T. A., Borman, A., Brown, L., Eades, C., Ferreras-Antolin, L., et al. (2025) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(25)00550-x · Cited by 32
Piqueras, A., Ganapathi, L., Carpenter, J. F., Rubio, T. T., Sandora, T. J., Flett, K. B., & Köhler, J. R. (2021) · Journal of Fungi · doi:10.3390/jof7020078 · Cited by 33
Machine learning to identify clinically relevant Candida yeast species
Shankarnarayan, S. A., & Charlebois, D. A. (2023) · Medical Mycology · doi:10.1093/mmy/myad134 · Cited by 30
Agnelli, C., Guimarães, T., Sukiennik, T., Lima, P. R. P., Salles, M. J. C., Breda, G. L., Queiroz‐Telles, F., Magri, M. M. C., Mendes, A. V. A., Camargo, L. F. A., et al. (2023) · Journal of Fungi · doi:10.3390/jof9040468 · Cited by 30
“Thus, aside from continuous medical education to guarantee an adequate level of early suspicion of candidemia even in lower-risk patients [29,34] and antifungal stewardship programs to assure rapid and effective antifungal initiation [35], investments on improving and providing more sensitive diagnostic methods with a…”
BackgroundPereira, F., & Rammaert, B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00230-5 · Cited by 30
Comparison of Three β-Glucan Tests for the Diagnosis of Invasive Candidiasis in Intensive Care Units
Kritikos, A., Caruana, G., Poissy, J., Mamin, A., Bachmann, D., Pagani, J., Coste, A. T., & Lamoth, F. (2023) · Journal of Clinical Microbiology · doi:10.1128/jcm.01691-22 · Cited by 29
Advancing Vaccine Strategies against Candida Infections: Exploring New Frontiers
Kaur, G., Chawla, S., Kumar, P., & Singh, R. (2023) · Vaccines · doi:10.3390/vaccines11111658 · Cited by 29
“The challenges posed in the diagnosis of Candida spp. infections are reviewed elsewhere in detail [15,16].”
BackgroundMixed Fungal Biofilms: From Mycobiota to Devices, a New Challenge on Clinical Practice
Costa, P. D. S., Prado, A., Bagon, N. P., Negri, M., & Svidzinski, T. I. E. (2022) · Microorganisms · doi:10.3390/microorganisms10091721 · Cited by 28
Soliman, M. F., Shetaia, Y. M., Tayel, A. A., Munshi, A. M., Alatawi, F. A., Alsieni, M., & Al‐Saman, M. A. (2022) · Antibiotics · doi:10.3390/antibiotics11030327 · Cited by 26
Rawson, T. M., Antcliffe, D. B., Wilson, R. C., Abdolrasouli, A., & Moore, L. S. P. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s390946 · Cited by 26
Severe Candida infections in critically ill patients with COVID-19
Koulenti, D., Karvouniaris, M., Paramythiotou, E., Koliakos, N. N., Μάρκου, Ν., Paranos, P., Meletiadis, J., & Blot, S. I. (2023) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2023.07.005 · Cited by 26
“[ 49 ] Finally, it is recommended to investigate the susceptibility profile of Candida species from non-sterile cultures to guide empirical antifungal therapy.”
BackgroundHu, W., Xu, D., Zhou, Z., Zhu, J., Wang, D., & Tang, J. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104826 · Cited by 25
Wang, J., Meng, S., Lin, K., Yi, X., Sun, Y., Xu, X., He, N., Zhang, Z., Hu, H., Qie, X., et al. (2022) · Analytica Chimica Acta · doi:10.1016/j.aca.2022.340658 · Cited by 25
Meneghello, S., Bernabé, G., Pietra, G. D., Sopra, S. D., Vecchio, C. D., Cattelan, A. M., Castagliuolo, I., & Brun, P. (2024) · Journal of Fungi · doi:10.3390/jof10100707 · Cited by 25
Wei, S., Wu, T. H., Wu, Y., Ding, M., & Zhu, X. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.10.017 · Cited by 25
Pote, S. T., Sonawane, M. S., Rahi, P., Shah, S. R., Shouche, Y. S., Patole, M. S., Thakar, M. R., & Sharma, R. K. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s238002 · Cited by 25
Soltani, S., Zandi, M., Faramarzi, S., Shahbahrami, R., Vali, M., Rezayat, S. A., Pakzad, R., Malekifar, P., Pakzad, I., Jahandoost, N., et al. (2022) · Osong Public Health and Research Perspectives · doi:10.24171/j.phrp.2021.0293 · Cited by 24
Dupuis, C., Bihan, C. L., Maubon, D., Calvet, L., Ruckly, S., Schwebel, C., Bouadma, L., Azoulay, É., Cornet, M., Timsit, J., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab080 · Cited by 24
Invasive candidiasis in intensive care medicine: shaping the future of diagnosis and therapy
Martín‐Loeches, I., Cornely, O. A., Denning, D. W., Guinea, J., Bassetti, M., Maertens, J. A., Hoenigl, M., Kanj, S. S., Slavin, M. A., Ostrosky-Zeichner, L. L., et al. (2025) · Intensive Care Medicine · doi:10.1007/s00134-025-08151-1 · Cited by 24
“Culture is still the reference for confirmation, yet sensitivity is often low, frequently below 40 percent, particularly in deep-seated disease or after antifungal exposure, and time to positivity may take days [24] [25].”
T2Candida Assay in the Diagnosis of Intraabdominal Candidiasis: A Prospective Multicenter Study
Krifors, A., Ullberg, M., Castegren, M., Petersson, J., Sparrelid, E., Hammarström, H., Sjölin, J., Özenci, V., & Blennow, O. (2022) · Journal of Fungi · doi:10.3390/jof8010086 · Cited by 23
“Therefore, efforts have been made to facilitate the early diagnosis of IC using screening protocols and novel diagnostic methods [9].”
BackgroundKrylov, V. B., Solovev, A. S., Puchkin, I. A., Yashunsky, D. V., Antonets, A. V., Kutsevalova, O. Y., & Nifantiev, N. E. (2021) · Journal of Fungi · doi:10.3390/jof7070504 · Cited by 23
Lorenzo-Villegas, D. L., Gohil, N. V., Lamo, P., Gurajala, S., Bagiu, I. C., Vulcănescu, D. D., Horhat, F. G., Sorop, V. B., Diaconu, M. M., Sorop, M. I., et al. (2023) · Life · doi:10.3390/life13102099 · Cited by 22
“The benefit of this method is the non-amplification of non-cell-associated, freely circulating DNA [75].”
MethodInfluentialSerological biomarkers of candidemia: a retrospective evaluation of three assays
Dichtl, K., Seybold, U., & Wagener, J. (2018) · Infection · doi:10.1007/s15010-018-1224-3 · Cited by 23
Cell wall polysaccharides from pathogenic fungi for diagnosis of fungal infectious disease
Osibe, D. A., Lei, S., Wang, B., Jin, C., & Fang, W. (2020) · Mycoses · doi:10.1111/myc.13101 · Cited by 22
Pietrobom, P. M. P., & Colombo, A. L. (2020) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000684 · Cited by 22
A Narrative Review of Invasive Candidiasis in the Intensive Care Unit
Noppè, E., Eloff, J. R. P., Keane, S., & Martín‐Loeches, I. (2024) · Therapeutic Advances in Pulmonary and Critical Care Medicine · doi:10.1177/29768675241304684 · Cited by 21
Fidel, P. L., Yano, J., Esher, S. K., & Noverr, M. C. (2020) · Journal of Fungi · doi:10.3390/jof6010035 · Cited by 21
Cento, V., Alteri, C., Mancini, V., Gatti, M., Lepera, V., Mazza, E., Moioli, M. C., Merli, M., Colombo, J., Orcese, C. A., et al. (2020) · Mycoses · doi:10.1111/myc.13170 · Cited by 22
Recent Challenges in Diagnosis and Treatment of Invasive Candidiasis in Neonates
Baltogianni, M. S., Giapros, V. I., & Dermitzaki, N. (2024) · Children · doi:10.3390/children11101207 · Cited by 20
“The T2 Candida system, an FDA-approved assay, can detect five Candida species ( Candida albicans , Candida tropicalis , Candida parapsilosis , Candida glabrata , and Candida krusei ) in whole blood specimens using T2MR technology [49,84].”
BackgroundMethodAlanio, A., Gits‐Muselli, M., Guigue, N., Denis, B., Bergeron, A., Touratier, S., Hamane, S., & Bretagne, S. (2021) · Medical Mycology · doi:10.1093/mmy/myab016 · Cited by 20
Mayer, L. M., Strich, J. R., Kadri, S. S., Lionakis, M. S., Evans, N. G., Prevots, D. R., & Ricotta, E. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac401 · Cited by 20
Murri, R., Camici, M., Posteraro, B., Giovannenze, F., Taccari, F., Ventura, G., Scoppettuolo, G., Sanguinetti, M., Cauda, R., & Fantoni, M. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s181489 · Cited by 20
“However, both molecular and nonmolecular diagnostic tests could be a strong support for more rapidly identifying patients who should start empirical antifungal treatment.(13) With regard to BDG, studies conducted in the ICU setting showed that BDG assay can be used to specifically improve the early discrimination betw…”
BackgroundDetection of Candida albicans Using a Manufactured Electrochemical Sensor
Dutta, P., Lu, Y.-J., Hsieh, H., Lee, T.-Y., Lee, Y., Cheng, C., & Fan, Y. (2021) · Micromachines · doi:10.3390/mi12020166 · Cited by 18
“Timely anti-fungal therapy and controlling the source of the infection are crucial de-terminants in terms of the survival of patients that have been infected by invasive candidiasis [18].”
BackgroundRapid diagnosis of invasive candidiasis: ready for prime-time?
Clancy, C. J., & Nguyen, M. H. (2019) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000594 · Cited by 17
“Sensitivity and specificity of BDG for intraabdominal candidiasis are taken from [10]).”
BackgroundSelf-citationNucleic Acid Tools for Invasive Fungal Disease Diagnosis
White, P. L., Alanio, A., Cruciani, M., Gorton, R., Millon, L., Rickerts, V., Barnes, R. A., Donnelly, J. P., & Loeffler, J. (2020) · Current Fungal Infection Reports · doi:10.1007/s12281-020-00374-7 · Cited by 17
Fungal Infection in Lung Transplantation
Kennedy, C. C., Pennington, K. M., Beam, E. N., & Razonable, R. R. (2021) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1729173 · Cited by 16
Dubey, R., Sen, K. K., Mohanty, S. S., Panda, S., Goyal, M., & Menon, S. M. (2022) · The Egyptian Journal of Radiology and Nuclear Medicine · doi:10.1186/s43055-022-00694-3 · Cited by 16
“In severe COVID-19 patients with a broader spectrum of antibacterial medications, parenteral diet and invasive examinations, or in patients with persistent neutropenia and other immune disability causes, the risk of Candida infection may increase dramatically [15].”
BackgroundMolecular Techniques and Target Selection for the Identification of Candida spp. in Oral Samples
Magalhães, J., Correia, M. J., Silva, R. M., Esteves, A. C., Alves, A., & Duarte, A. S. (2022) · Applied Sciences · doi:10.3390/app12189204 · Cited by 16
“…mortality rates in Candida infections are in part justified by diagnostic inaccuracy (i.e., incorrect identification at the species level and of the drug resistance profile), which may compromise the administration of adequate antifungal therapies and ultimately lead to the patient’s death [27–29].”
BackgroundAşkun, T. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100869 · Cited by 16
Linder, K. A., Kauffman, C. A., Zhou, S., Richards, B. J., Kleiboeker, S. B., & Miceli, M. H. (2020) · Mycopathologia · doi:10.1007/s11046-020-00479-0 · Cited by 15
Price, J. S., Fallon, M., Posso, R. B., Backx, M., & White, P. L. (2022) · Journal of Fungi · doi:10.3390/jof8090935 · Cited by 15
“For example, in a patient with small bowel perforation and a positive serum BDG, the probability of IC is 39%, which would be increased further by the presence of Candida colonization, particularly of central venous catheters or deep wounds [11].”
BackgroundMethodResultInfluential
Metadata
- Authors
- Clancy, C. J., & Nguyen, M. H.
- Affiliations
- University of Pittsburgh (US)
- VA Pittsburgh Healthcare System (US)
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2018-05
- Volume
- 56
- Issue
- 5
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC5925725
- OpenAlex
- W2790020787
- Cited by
- 293
- References
- 30
- Citations by year
- 2026: 30 · 2025: 38 · 2024: 34 · 2023: 46 · 2022: 38 · 2021: 45 · 2020: 33 · 2019: 21 · 2018: 8
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- invasive candidiasis, candidemia, germ tube test, β-1,3-glucan, PCR, diagnostic performance, positive predictive value, negative predictive value, pretest probability
- MeSH terms
- Clinical Decision-Making, Antibodies, Fungal, Antigens, Fungal, Candida, DNA, Fungal, Sensitivity and Specificity, Clinical Laboratory Techniques, Candidiasis, Invasive, Intraabdominal Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.